Scotland-based privately held company XstalBio has introduced new patented reconstitution technology, CentuRecon, to accelerate the delivery of biologic drugs at high concentration. The technology facilitates the preparation of dry ...
Tags: XstalBio, Drugs Delivery
Biogen has announced acceptance of marketing applications of Plegridy(peginterferon beta-1a) for review by the US and EU regulatory authorities. Plegridy, a member of the interferon class of treatments, is a pegylated subcutaneous ...
Tags: Biogen, Marketing Applications
US-based RTI Biologics, a manufacturer of orthopaedic and other biologic implants, has completed the acquisition of Pioneer Surgical Technology for $130m in an all-cash deal. RTI Biologics announced its plans to acquire Pioneer on 12 June ...
Tags: Health, Medicine, RTI Biologics, biologic implants
Green Biologics Limited , a UK-based industrial biotechnology company with pilot scale facilities and offices in Columbus, Ohio, has announced a collaboration and planned investment in facilities with Easy Energy Systems Inc. The ...
Tags: Construction, Decoration, Chemicals
Genentech, a member of the Roche Group, has obtained FDA priority review status for Obinutuzumab (GA101) to treat previously untreated chronic lymphocytic leukemia (CLL). The FDA has also accepted the company's biologics license ...
Tags: Genentech, FDA Priority
MicroPort Medical, a subsidiary of MicroPort Scientific, has signed a definitive agreement with Wright Medical Group, a US-based orthopaedic company, to acquire Wright's OrthoRecon business for $290m in cash. The transaction is subject to ...
Tags: Microport Medical, Medicine
"The iTrace for Blood Centers device has the ability to enhance blood safety by helping to ensure that unsuitable units are not released," said Karen Midthun, M.D., director of the FDA's Center for Biologics Evaluation and Research. "iTrace ...
Tags: Blood Tracking Device, Health, Medicine
Medtronic has received CE Mark (Conformité Européenne) for its ReDuX Plier, a new instrument specially intended for use during osteotomies. With the approval, the company has also announced the launch of the surgical ...
The US FDA has cleared Sanofi Pasteur's supplemental biologics license application (sBLA) licensing four-strain influenza vaccine, Fluzone Quadrivalent, for broad age range of children and adults. As the first and only four-strain ...
Tags: Influenza Vaccine, Medicine
Pfizer has collaborated with the University of California, San Francisco (UCSF) to expand its centers for therapeutic innovation (CTI) into the development of small-molecule drug candidates and enhance its drug discovery capabilities. ...
SCHOTT North America has introduced the smallest in the Laboratory Bottle lineup, the 10mL Duran laboratory bottle with high chemical resistance through the full temperature range. The new Duran 10mL laboratory 3.3 borosilicate glass ...
Tags: Laboratory Bottle, Medicine
Schott North America has announced the availability of the latest size of its DURAN Laboratory Bottles, of 10ml. According to the US-based company, the new 3.3 borosilicate glass bottles are suitable for a range of uses, from storage ...
Tags: Glass Bottles, Packaging
Biogen Idec is seeking FDA approval for Plegridy (Peginterferon Beta-1a) as multiple sclerosis (MS) medication. The company submitted a biologics license application (BLA) to the FDA for its pegylated subcutaneous injectable candidate ...
Tags: Biogen IDEC, FDA Approval
Merck, referred to as MSD outside the US and Canada, has announced the FDA acceptance of biologics license application (BLA) of investigational ragweed pollen (Ambrosia artemisiifolia) sublingual allergy immunotherapy tablet for review. ...
Tags: Merck Biologics, Medicine
Spinal device company K2M has added a new biologics offering to its VESUVIUS Osteobiologic Systems product portfolio. Featuring VESUVIUS Demineralized Fibers and VESUVIUS Demineralized Sponge, the new VESUVIUS DBM Putty includes a ...
Tags: K2M, Vesuvius DBM Putty